Improved intestinal absorption of a poorly water-soluble oral drug using mannitol microparticles containing a nanosolid drug dispersion. 2012

Yukiko Nishino, and Aya Kubota, and Takanori Kanazawa, and Yuuki Takashima, and Tetsuya Ozeki, and Hiroaki Okada
Laboratory of Pharmaceutics and Drug Delivery, Department of Pharmaceutical Science, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan.

A nozzle for a spray dryer that can prepare microparticles of water-soluble carriers containing various nanoparticles in a single step was previously developed in our laboratory. To enhance the solubility and intestinal absorption of poorly water-soluble drugs, we used probucol (PBL) as a poorly water-soluble drug, mannitol (MAN) as a water-soluble carrier for the microparticles, and EUDRAGIT (EUD) as a polymer vehicle for the solid dispersion. PBL-EUD-acetone-methanol and aqueous MAN solutions were simultaneously supplied through different liquid passages of the spray nozzle and dried together. PBL-EUD solid dispersion was nanoprecipitated in the MAN solution using an antisolvent mechanism and rapidly dried by surrounding it with MAN. PBL in the dispersion vehicle was amorphous and had higher physical stability according to powder X-ray diffraction and differential scanning calorimetry analysis. The bioavailability of PBL in PBL-EUD S-100-MAN microparticles after oral administration in rats was markedly higher (14- and 6.2-fold, respectively) than that of the original PBL powder and PBL-MAN microparticles. These results demonstrate that the composite microparticles containing a nanosized solid dispersion of a poorly water-soluble drug prepared using the spray nozzle developed by us should be useful to increase the solubility and bioavailability of drugs after oral administration.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008297 Male Males
D008353 Mannitol A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity. (L)-Mannitol,Osmitrol,Osmofundin
D008855 Microscopy, Electron, Scanning Microscopy in which the object is examined directly by an electron beam scanning the specimen point-by-point. The image is constructed by detecting the products of specimen interactions that are projected above the plane of the sample, such as backscattered electrons. Although SCANNING TRANSMISSION ELECTRON MICROSCOPY also scans the specimen point by point with the electron beam, the image is constructed by detecting the electrons, or their interaction products that are transmitted through the sample plane, so that is a form of TRANSMISSION ELECTRON MICROSCOPY. Scanning Electron Microscopy,Electron Scanning Microscopy,Electron Microscopies, Scanning,Electron Microscopy, Scanning,Electron Scanning Microscopies,Microscopies, Electron Scanning,Microscopies, Scanning Electron,Microscopy, Electron Scanning,Microscopy, Scanning Electron,Scanning Electron Microscopies,Scanning Microscopies, Electron,Scanning Microscopy, Electron
D008863 Microspheres Small uniformly-sized spherical particles, of micrometer dimensions, frequently labeled with radioisotopes or various reagents acting as tags or markers. Latex Beads,Latex Particles,Latex Spheres,Microbeads,Bead, Latex,Beads, Latex,Latex Bead,Latex Particle,Latex Sphere,Microbead,Microsphere,Particle, Latex,Particles, Latex,Sphere, Latex,Spheres, Latex
D010599 Pharmacokinetics Dynamic and kinetic mechanisms of exogenous chemical DRUG LIBERATION; ABSORPTION; BIOLOGICAL TRANSPORT; TISSUE DISTRIBUTION; BIOTRANSFORMATION; elimination; and DRUG TOXICITY as a function of dosage, and rate of METABOLISM. LADMER, ADME and ADMET are abbreviations for liberation, absorption, distribution, metabolism, elimination, and toxicology. ADME,ADME-Tox,ADMET,Absorption, Distribution, Metabolism, Elimination, and Toxicology,Absorption, Distribution, Metabolism, and Elimination,Drug Kinetics,Kinetics, Drug,LADMER,Liberation, Absorption, Distribution, Metabolism, Elimination, and Response
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D014867 Water A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Hydrogen Oxide

Related Publications

Yukiko Nishino, and Aya Kubota, and Takanori Kanazawa, and Yuuki Takashima, and Tetsuya Ozeki, and Hiroaki Okada
March 1996, Chemical & pharmaceutical bulletin,
Yukiko Nishino, and Aya Kubota, and Takanori Kanazawa, and Yuuki Takashima, and Tetsuya Ozeki, and Hiroaki Okada
July 2006, International journal of pharmaceutics,
Yukiko Nishino, and Aya Kubota, and Takanori Kanazawa, and Yuuki Takashima, and Tetsuya Ozeki, and Hiroaki Okada
January 1996, Biopharmaceutics & drug disposition,
Yukiko Nishino, and Aya Kubota, and Takanori Kanazawa, and Yuuki Takashima, and Tetsuya Ozeki, and Hiroaki Okada
April 1994, Journal of pharmaceutical sciences,
Yukiko Nishino, and Aya Kubota, and Takanori Kanazawa, and Yuuki Takashima, and Tetsuya Ozeki, and Hiroaki Okada
July 2010, Therapeutic delivery,
Yukiko Nishino, and Aya Kubota, and Takanori Kanazawa, and Yuuki Takashima, and Tetsuya Ozeki, and Hiroaki Okada
October 2019, Pharmaceutical development and technology,
Yukiko Nishino, and Aya Kubota, and Takanori Kanazawa, and Yuuki Takashima, and Tetsuya Ozeki, and Hiroaki Okada
March 2012, AAPS PharmSciTech,
Yukiko Nishino, and Aya Kubota, and Takanori Kanazawa, and Yuuki Takashima, and Tetsuya Ozeki, and Hiroaki Okada
September 2022, Journal of controlled release : official journal of the Controlled Release Society,
Yukiko Nishino, and Aya Kubota, and Takanori Kanazawa, and Yuuki Takashima, and Tetsuya Ozeki, and Hiroaki Okada
January 2016, International journal of pharmaceutics,
Yukiko Nishino, and Aya Kubota, and Takanori Kanazawa, and Yuuki Takashima, and Tetsuya Ozeki, and Hiroaki Okada
June 2011, Molecular pharmaceutics,
Copied contents to your clipboard!